Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01399359 · ClinicalTrials.gov registry record
Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer
A clinical trial, sponsored by NSABP Foundation.
- Completed
- Registry status
- 1,023
- Enrollment target
NCT01399359: Completed study, sponsored by NSABP Foundation.
NCT01399359 is a clinical trial that has completed, run by NSABP Foundation. The registered enrollment target is 1,023 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01399359 has completed, sponsored by NSABP Foundation.
- COMPLETED
- Registry status
- 1,023 participants
- Enrollment target
Study Summary
RATIONALE: Learning about how patients make decisions about using chemoprevention may help doctors plan treatment in which more patients are willing to choose chemoprevention to reduce their breast cancer risk. PURPOSE: This clinical trial studies factors influencing decision-making about the use of chemoprevention in women at increased risk for breast cancer.
Interventions
- BEHAVIORAL Counseling session
- OTHER Questionnaire 1
- OTHER Questionnaire 2
- OTHER online questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,023 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-10 |
What the finished NCT01399359 record still lists
NCT01399359 is an observational study that tracks outcomes without assigning an intervention. Its 1,023 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which Counseling session is the first listed.
NCT01399359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01399359 about?
NCT01399359 is a clinical study titled "Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer". RATIONALE: Learning about how patients make decisions about using chemoprevention may help doctors plan treatment in which more patients are willing to choose chemoprevention to reduce their breast cancer risk. PURPOSE: This clinical trial studies factors influencing decision-making about the use o...
What is the current status of trial NCT01399359?
This trial is currently completed. The enrollment target is 1,023 participants. The study started on 2011-08. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01399359?
The interventions under investigation include: Counseling session (BEHAVIORAL), Questionnaire 1 (OTHER), Questionnaire 2 (OTHER), online questionnaire (OTHER).
Who is sponsoring clinical trial NCT01399359?
This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07216703 · 1,023 participants · Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia